Elaine Shanks, Ph.D.

Associate Director - Clinical Delivery, Program Lead Exploratory Medicine and Pharmacology
Eli Lilly and Company, United Kingdom

Poster(s):

• (T0930-02-07) Evaluation of the Effect of Food and Gastric pH Change on the Pharmacokinetics and Safety of Imlunestrant in Healthy Volunteers
  Tuesday, October 22, 2024

  9:30 AM – 10:30 AM MT

• (W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
  Wednesday, October 23, 2024

  9:30 AM – 10:30 AM MT

• (T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
  Tuesday, October 22, 2024

  11:30 AM – 12:30 PM MT